<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) has several cutaneous complications: <z:hpo ids='HP_0000992'>photosensitivity</z:hpo> is well known, but the other complications are rarely reported, Since late 1997, we have studied the dermatologic complications of using porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="7" ids="53228">PDT</z:chebi> to treat either <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:e sem="disease" ids="C1112160" disease_type="Neoplastic Process" abbrv="">gastroesophageal cancer</z:e> in 72 consecutive patients </plain></SENT>
<SENT sid="1" pm="."><plain>Cutaneous complications of <z:chebi fb="7" ids="53228">PDT</z:chebi> included serious <z:mp ids='MP_0005653'>phototoxicity</z:mp> requiring oral <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> treatment (22 patients; 31%), <z:e sem="disease" ids="C0019360" disease_type="Disease or Syndrome" abbrv="ZONA">herpes zoster</z:e> (HZ) requiring hospitalization and intravenous antiviral treatment (1 patient; 1%), and <z:hpo ids='HP_0010783'>erythema</z:hpo> multiforme drug reaction related to porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> (1 patient; 1%) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi>-associated dermatologic complications were common and were not related to <z:hpo ids='HP_0000992'>cutaneous photosensitivity</z:hpo> </plain></SENT>
</text></document>